-
Post date
March 18, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks, Canadian psychedelics companies, Canadian psychedelics market, clinical trials psychedelics, Dealer's License, Health Canada approval, licensed dealer, medical psychedelics, mushroom, mushroom formulation, mushroom laws, mushroom legalization, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, natural psychedelics, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin mushrooms, Psychedelics, psychedelics stocks 2022
-
Post date
August 9, 2021
-
Posted by
Vishal Toora
-
Posted in
Best Canadian extraction companies, Cannabis, cannabis extraction, cannabis extraction stocks, Featured Content, mushroom, Mushrooms, Psychedelics, Pure Extracts, Scribes, Series, Toora
-
Post date
August 9, 2021
-
Posted by
Vishal Toora
-
Posted in
Best Canadian extraction companies, Cannabis, cannabis extraction, cannabis extraction stocks, Featured Content, mushroom, Mushrooms, Psychedelics, Pure Extracts, Toora
-
Post date
June 28, 2021
-
Posted by
Piers Eaton
-
Posted in
Adelia Therapeutics, Biotech, Cash on had, Cash on hand, cybin, CYBN.NE, Eaton, financial results, Health Science, Milestones, mushroom, Mushrooms, psilocybin, Psychedelics, research, Science, Scribes, shrooms
-
Post date
April 27, 2021
-
Posted by
Lukas Kane
-
Posted in
5 best Canadian Biotechs, Biotech, Biotech collaborations, Bucillamine, Canadian Biotech, cancer treatment, Cannabis, clinical sites, Covid-19 treatment, CRO, CymaBay Therapeutics (CBAY.NASDAQ), Fabio Chianelli, Featured Content, Health Science, Institutional Review Board, Investigational new drug, IRB, Kane, liver disease, massive buying, mushroom, mushroom research, Mushrooms, Novotech, Pharm-Olam LLC, PharmaTher, PharmaTher (PHRM.C), Phase 3 FDA trial, Phase 3 trial, Psychedelics, research, resperitory viral infections, Revive Therapeutics, RVV.C, Scribes, Series, shrooms, stock price surge, undervalued bio tech companies, wealth creation
